Influence of nutritional status and body composition on postoperative events and outcome in patients treated for primary localized retroperitoneal sarcoma

1. Van Tine BA. 90 - Sarcomas of soft tissue. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, editors. Abeloff's clinical oncology (Sixth Edition). Philadelphia: Elsevier; 2019. p. 1655-93.e11. Van TineBA 90 - Sarcomas of soft tissue In: NiederhuberJE ArmitageJO KastanMB DoroshowJH TepperJE editors. Abeloff's clinical oncology Sixth Edition Philadelphia Elsevier 2019 1655-93.e11 Search in Google Scholar

2. Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013; 49: 684–95. doi: 10.1016/j.ejca.2012.09.011 StillerCA TramaA SerrainoD RossiS NavarroC ChirlaqueMD Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project Eur J Cancer 2013 49 684 95 10.1016/j.ejca.2012.09.011 Open DOISearch in Google Scholar

3. Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. The value of surgery for retroperitoneal sarcoma. Sarcoma 2009; 2009: 605840. doi: 10.1155/2009/605840 GholamiS JacobsCD KappDS ParastLM NortonJA The value of surgery for retroperitoneal sarcoma Sarcoma 2009 2009 605840 10.1155/2009/605840 Open DOISearch in Google Scholar

4. Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015; 22: 256–63. doi: 10.1245/s10434-014-3965-2 Trans-Atlantic RPSWG Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group Ann Surg Oncol 2015 22 256 63 10.1245/s10434-014-3965-2 Open DOISearch in Google Scholar

5. Trans-Atlantic RPSWG. Erratum to: Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2017; 24: 688–9. doi: 10.1245/s10434-017-5889-0 Trans-Atlantic RPSWG Erratum to: Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group Ann Surg Oncol 2017 24 688 9 10.1245/s10434-017-5889-0 Open DOISearch in Google Scholar

6. Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2020; 21: 1366–77. doi: 10.1016/s1470-2045(20)30446-0 BonvalotS GronchiA Le PéchouxC SwallowCJ StraussD MeeusP Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial Lancet Oncol 2020 21 1366 77 10.1016/s1470-2045(20)30446-0 Open DOISearch in Google Scholar

7. Bonvalot S, Gronchi A, Le Pechoux C, Swallow CJ, Strauss DC, Meeus P, et al. STRASS (EORTC 62092): a phase III randomized study of preoperative radio-therapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. [abstract]. J Clin Oncol 2019; 37(15 Sppl): 11001. doi: 10.1200/JCO.2019.37.15_suppl.11001 BonvalotS GronchiA Le PechouxC SwallowCJ StraussDC MeeusP STRASS (EORTC 62092): a phase III randomized study of preoperative radio-therapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. [abstract] J Clin Oncol 2019 37 15 Sppl 11001 10.1200/JCO.2019.37.15_suppl.11001 Open DOISearch in Google Scholar

8. Callegaro D, Raut CP, Ajayi T, Strauss D, Bonvalot S, Ng D, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) versus off-trial (STREXIT) results. Ann Surg 2023; 278: 127–34. doi: 10.1097/sla.0000000000005492 CallegaroD RautCP AjayiT StraussD BonvalotS NgD Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) versus off-trial (STREXIT) results Ann Surg 2023 278 127 34 10.1097/sla.0000000000005492 Open DOISearch in Google Scholar

9. Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19: 2981–91. doi: 10.1245/s10434-012-2342-2 BonvalotS RautCP PollockRE RutkowskiP StraussDC HayesAJ Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG Ann Surg Oncol 2012 19 2981 91 10.1245/s10434-012-2342-2 Open DOISearch in Google Scholar

10. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27: 31–7. doi: 10.1200/jco.2008.18.0802 BonvalotS RivoireM CastaingM StoeckleE Le CesneA BlayJY Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control J Clin Oncol 2009 27 31 7 10.1200/jco.2008.18.0802 Open DOISearch in Google Scholar

11. Gutierrez JC, Perez EA, Moffat FL, Livingstone AS, Franceschi D, Koniaris LG. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007; 245: 952–8. doi: 10.1097/01.sla.0000250438.04393.a8 GutierrezJC PerezEA MoffatFL LivingstoneAS FranceschiD KoniarisLG Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients Ann Surg 2007 245 952 8 10.1097/01.sla.0000250438.04393.a8 Open DOISearch in Google Scholar

12. van Dalen T, Hennipman A, Van Coevorden F, Hoekstra HJ, van Geel BN, Slootweg P, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004; 11: 483–90. doi: 10.1245/aso.2004.09.005 van DalenT HennipmanA Van CoevordenF HoekstraHJ van GeelBN SlootwegP Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma Ann Surg Oncol 2004 11 483 90 10.1245/aso.2004.09.005 Open DOISearch in Google Scholar

13. Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, et al. ECCO Essential Requirements for Quality Cancer Care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol 2017; 110: 94–105. doi: 10.1016/j.critrevonc.2016.12.002 AndritschE BeishonM BielackS BonvalotS CasaliP CrulM ECCO Essential Requirements for Quality Cancer Care: soft tissue sarcoma in adults and bone sarcoma. A critical review Crit Rev Oncol Hematol 2017 110 94 105 10.1016/j.critrevonc.2016.12.002 Open DOISearch in Google Scholar

14. Novak M, Perhavec A, Povšič M, Arnuš M, Eržen D. Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center. World J Surg Oncol 2020; 18: 277. doi: 10.1186/s12957-020-02038-9 NovakM PerhavecA PovšičM ArnušM ErženD Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center World J Surg Oncol 2020 18 277 10.1186/s12957-020-02038-9 Open DOISearch in Google Scholar

15. Balderas-Pena LM, Gonzalez-Barba F, Martinez-Herrera BE, Palomares-Chacon UR, Duran-Anguiano O, Salazar-Paramo M, et al. Body composition and biochemical parameters of nutritional status: correlation with health-related quality of life in patients with colorectal cancer. Nutrients 2020; 12: 2110. doi: 10.3390/nu12072110 Balderas-PenaLM Gonzalez-BarbaF Martinez-HerreraBE Palomares-ChaconUR Duran-AnguianoO Salazar-ParamoM Body composition and biochemical parameters of nutritional status: correlation with health-related quality of life in patients with colorectal cancer Nutrients 2020 12 2110 10.3390/nu12072110 Open DOISearch in Google Scholar

16. Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutri 2017; 36: 1187–96. doi: 10.1016/j.clnu.2017.06.017 ArendsJ BaracosV BertzH BozzettiF CalderPC DeutzNEP ESPEN expert group recommendations for action against cancer-related malnutrition Clin Nutri 2017 36 1187 96 10.1016/j.clnu.2017.06.017 Open DOISearch in Google Scholar

17. Kirov KM, Xu HP, Crenn P, Goater P, Tzanis D, Bouhadiba MT, et al. Role of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience. Eur J Surg Oncol 2019; 45: 261–7. doi: 10.1016/j.ejso.2018.07.001 KirovKM XuHP CrennP GoaterP TzanisD BouhadibaMT Role of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience Eur J Surg Oncol 2019 45 261 7 10.1016/j.ejso.2018.07.001 Open DOISearch in Google Scholar

18. Previtali P, Fiore M, Colombo J, Arendar I, Fumagalli L, Pizzocri M, et al. Malnutrition and perioperative nutritional support in retroperitoneal sarcoma patients: results from a prospective study. Ann Surg Oncol 2020; 27: 2025–32. doi: 10.1245/s10434-019-08121-0 PrevitaliP FioreM ColomboJ ArendarI FumagalliL PizzocriM Malnutrition and perioperative nutritional support in retroperitoneal sarcoma patients: results from a prospective study Ann Surg Oncol 2020 27 2025 32 10.1245/s10434-019-08121-0 Open DOISearch in Google Scholar

19. Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 2018; 23: 97–104. doi: 10.1634/theoncologist.2017-0255 NippRD FuchsG El-JawahriA MarioJ TroschelFM GreerJA Sarcopenia is associated with quality of life and depression in patients with advanced cancer Oncologist 2018 23 97 104 10.1634/theoncologist.2017-0255 Open DOISearch in Google Scholar

20. Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016; 17: 767.e1–7. doi: 10.1016/j.jamda.2016.05.016 ChenLK LeeWJ PengLN LiuLK AraiH AkishitaM Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia J Am Med Dir Assoc 2016 17 767.e1 7 10.1016/j.jamda.2016.05.016 Open DOISearch in Google Scholar

21. Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant 2020; 20: 493–503. doi: 10.1111/ajt.15577 CziganyZ KrampW BednarschJ van der KroftG BoeckerJ StrnadP Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation Am J Transplant 2020 20 493 503 10.1111/ajt.15577 Open DOISearch in Google Scholar

22. Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, et al. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study. Eur J Surg Oncol 2020; 46: 1656–62. doi: 10.1016/j.ejso.2020.03.206 AroR Mäkäräinen-UhlbäckE ÄmmäläN RautioT OhtonenP SaarnioJ The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study Eur J Surg Oncol 2020 46 1656 62 10.1016/j.ejso.2020.03.206 Open DOISearch in Google Scholar

23. Rier HN, Jager A, Sleijfer S, Maier AB, Levin MD. The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature. Oncologist 2016; 21: 1396–409. doi: 10.1634/theoncologist.2016-0066 RierHN JagerA SleijferS MaierAB LevinMD The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature Oncologist 2016 21 1396 409 10.1634/theoncologist.2016-0066 Open DOISearch in Google Scholar

24. Deng CY, Lin YC, Wu JS, Cheung YC, Fan CW, Yeh KY, et al. Progressive sarcopenia in patients with colorectal cancer predicts survival. AJR Am J Roentgenol 2018; 210: 526–32. doi: 10.2214/ajr.17.18020 DengCY LinYC WuJS CheungYC FanCW YehKY Progressive sarcopenia in patients with colorectal cancer predicts survival AJR Am J Roentgenol 2018 210 526 32 10.2214/ajr.17.18020 Open DOISearch in Google Scholar

25. Jung AR, Roh JL, Kim JS, Kim SB, Choi SH, Nam SY, et al. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer. Eur J Cancer 2019; 116: 98–106. doi: 10.1016/j.ejca.2019.05.006 JungAR RohJL KimJS KimSB ChoiSH NamSY Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer Eur J Cancer 2019 116 98 106 10.1016/j.ejca.2019.05.006 Open DOISearch in Google Scholar

26. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629–35. doi: 10.1016/S1470-2045(08)70153-0 PradoCM LieffersJR McCargarLJ ReimanT SawyerMB MartinL Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 2008 9 629 35 10.1016/S1470-2045(08)70153-0 Open DOISearch in Google Scholar

27. Strassmann D, Hensen B, Grünwald V, Stange K, Eggers H, Länger F, et al. Impact of sarcopenia in advanced and metastatic soft tissue sarcoma. Int J Clin Oncol 2021; 26: 2151–60. doi: 10.1007/s10147-021-01997-7 StrassmannD HensenB GrünwaldV StangeK EggersH LängerF Impact of sarcopenia in advanced and metastatic soft tissue sarcoma Int J Clin Oncol 2021 26 2151 60 10.1007/s10147-021-01997-7 Open DOISearch in Google Scholar

28. Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes 2014; 21: 345–51. doi: 10.1097/med.0000000000000093 BaysH Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction Curr Opin Endocrinol Diabetes Obes 2014 21 345 51 10.1097/med.0000000000000093 Open DOISearch in Google Scholar

29. Boyle EA, Elliott JA, McIntyre TV, Barnes ME, Donlon NE, Umair M, et al. Body composition is associated with operative and oncologic outcomes in the management of retroperitoneal and trunk soft tissue sarcoma. Am J Surg 2022; 223: 729–37. doi: 10.1016/j.amjsurg.2021.08.005 BoyleEA ElliottJA McIntyreTV BarnesME DonlonNE UmairM Body composition is associated with operative and oncologic outcomes in the management of retroperitoneal and trunk soft tissue sarcoma Am J Surg 2022 223 729 37 10.1016/j.amjsurg.2021.08.005 Open DOISearch in Google Scholar

30. O'Sullivan J, Lysaght J, Donohoe CL, Reynolds JV. Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments. Nat Rev Gastroenterol Hepatol 2018; 15: 699–714. doi: 10.1038/s41575-018-0069-7 O'SullivanJ LysaghtJ DonohoeCL ReynoldsJV Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments Nat Rev Gastroenterol Hepatol 2018 15 699 714 10.1038/s41575-018-0069-7 Open DOISearch in Google Scholar

31. Shirazipour CH, Freedland SJ. Obesity, visceral adiposity, and prostate cancer: what is the role of lifestyle interventions? Cancer 2019; 125: 2730–1. doi: 10.1002/cncr.32165 ShirazipourCH FreedlandSJ Obesity, visceral adiposity, and prostate cancer: what is the role of lifestyle interventions? Cancer 2019 125 2730 1 10.1002/cncr.32165 Open DOISearch in Google Scholar

32. Baastrup NN, Christensen JK, Jensen KK, Jørgensen LN. Visceral obesity and short-term outcomes after laparoscopic rectal cancer resection. Surg Endosc 2020; 34: 177–85. doi: 10.1007/s00464-019-06748-4 BaastrupNN ChristensenJK JensenKK JørgensenLN Visceral obesity and short-term outcomes after laparoscopic rectal cancer resection Surg Endosc 2020 34 177 85 10.1007/s00464-019-06748-4 Open DOISearch in Google Scholar

33. Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev 2021; 22: e13088. doi: 10.1111/obr.13088 SilveiraEA KliemannN NollM SarrafzadeganN de OliveiraC Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence Obes Rev 2021 22 e13088 10.1111/obr.13088 Open DOISearch in Google Scholar

34. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of skeletal muscle mass index, intramuscular adipose zissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation 2017; 101: 565–74. doi: 10.1097/tp.0000000000001587 HamaguchiY KaidoT OkumuraS KobayashiA ShiraiH YagiS Impact of skeletal muscle mass index, intramuscular adipose zissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation Transplantation 2017 101 565 74 10.1097/tp.0000000000001587 Open DOISearch in Google Scholar

35. Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, et al. Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma. Ann Surg Oncol 2016; 23: 1387–94. doi: 10.1245/s10434-015-5018-x OkamuraA WatanabeM MineS NishidaK ImamuraY KurogochiT Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma Ann Surg Oncol 2016 23 1387 94 10.1245/s10434-015-5018-x Open DOISearch in Google Scholar

36. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer 2019; 8: 92–109. doi: 10.1159/000488779 HamaguchiY KaidoT OkumuraS KobayashiA ShiraiH YaoS Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma Liver Cancer 2019 8 92 109 10.1159/000488779 Open DOISearch in Google Scholar

37. Grignol VP, Smith AD, Shlapak D, Zhang X, Del Campo SM, Carson WE. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy. Surg Oncol 2015; 24: 353–8. doi: 10.1016/j.suronc.2015.09.002 GrignolVP SmithAD ShlapakD ZhangX Del CampoSM CarsonWE Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy Surg Oncol 2015 24 353 8 10.1016/j.suronc.2015.09.002 Open DOISearch in Google Scholar

38. Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 2018; 29: ii1–9. doi: 10.1093/annonc/mdx810 BaracosVE ArribasL Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy Ann Oncol 2018 29 ii1 9 10.1093/annonc/mdx810 Open DOISearch in Google Scholar

39. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 2022; 41: 990–1000. doi: 10.1016/j.clnu.2021.11.014 DoniniLM BusettoL BischoffSC CederholmT Ballesteros-PomarMD BatsisJA Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement Clin Nutr 2022 41 990 1000 10.1016/j.clnu.2021.11.014 Open DOISearch in Google Scholar

40. Vehmas T, Kairemo KJ, Taavitsainen MJ. Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord 1996; 20: 570–3. PMID: 8782734 VehmasT KairemoKJ TaavitsainenMJ Measuring visceral adipose tissue content from contrast enhanced computed tomography Int J Obes Relat Metab Disord 1996 20 570 3 PMID: 8782734 Search in Google Scholar

41. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115–22. doi: 10.1152/jappl.1998.85.1.115 MitsiopoulosN BaumgartnerRN HeymsfieldSB LyonsW GallagherD RossR Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography J Appl Physiol 1998 85 115 22 10.1152/jappl.1998.85.1.115 Open DOISearch in Google Scholar

42. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes 2007; 31: 500–6. doi: 10.1038/sj.ijo.0803454 Maurovich-HorvatP MassaroJ FoxCS MoselewskiF O'DonnellCJ HoffmannU Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography Int J Obes 2007 31 500 6 10.1038/sj.ijo.0803454 Open DOISearch in Google Scholar

43. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997–1006. doi: 10.1139/H08-075 MourtzakisM PradoCM LieffersJR ReimanT McCargarLJ BaracosVE A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care Appl Physiol Nutr Metab 2008 33 997 1006 10.1139/H08-075 Open DOISearch in Google Scholar

44. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13. doi: 10.1097/01.sla.0000133083.54934.ae DindoD DemartinesN ClavienPA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 2004 240 205 13 10.1097/01.sla.0000133083.54934.ae Open DOISearch in Google Scholar

45. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37–42. doi: 10.1002/ijc.2910330108 TrojaniM ContessoG CoindreJM RouesseJ BuiNB de MascarelA Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 1984 33 37 42 10.1002/ijc.2910330108 Open DOISearch in Google Scholar

46. Popuri K, Cobzas D, Esfandiari N, Baracos V, Jägersand M. Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle. IEEE Trans Med Imaging 2016; 35: 512–20. doi: 10.1109/tmi.2015.2479252 PopuriK CobzasD EsfandiariN BaracosV JägersandM Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle IEEE Trans Med Imaging 2016 35 512 20 10.1109/tmi.2015.2479252 Open DOISearch in Google Scholar

47. Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, et al. Establishing computed tomography – defined visceral fat area thresholds for use in obesity – related cancer research. Nutr Res 2013; 33: 171–9. doi: 10.1016/j.nutres.2012.12.007 DoyleSL BennettAM DonohoeCL MonganAM HowardJM LithanderFE Establishing computed tomography – defined visceral fat area thresholds for use in obesity – related cancer research Nutr Res 2013 33 171 9 10.1016/j.nutres.2012.12.007 Open DOISearch in Google Scholar

48. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 601. doi: 10.1093/ageing/afz046 Cruz-JentoftAJ BahatG BauerJ BoirieY BruyereO CederholmT Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 2019 48 601 10.1093/ageing/afz046 Open DOISearch in Google Scholar

49. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489–95. doi: 10.1016/s1470-2045(10)70218-7 FearonK StrasserF AnkerSD BosaeusI BrueraE FainsingerRL Definition and classification of cancer cachexia: an international consensus Lancet Oncol 2011 12 489 95 10.1016/s1470-2045(10)70218-7 Open DOISearch in Google Scholar

50. Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 1999; 30: 253–70. doi: 10.1016/S0167-9473(98)00096-6 ContalC O'QuigleyJ An application of changepoint methods in studying the effect of age on survival in breast cancer Comput Stat Data Anal 1999 30 253 70 10.1016/S0167-9473(98)00096-6 Open DOISearch in Google Scholar

51. Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 2017; 26: 1008–15. doi: 10.1158/1055-9965.Epi-17-0200 CaanBJ MeyerhardtJA KroenkeCH AlexeeffS XiaoJ WeltzienE Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study) Cancer Epidemiol Biomarkers Prev 2017 26 1008 15 10.1158/1055-9965.Epi-17-0200 Open DOISearch in Google Scholar

52. Hassen W, Kassambara A, Reme T, Sahota S, Seckinger A, Vincent L, et al. Drug metabolism and clearance system in tumor cells of patients with multiple myeloma. Oncotarget 2015; 6: 6431–47. doi: 10.18632/oncotarget.3237 HassenW KassambaraA RemeT SahotaS SeckingerA VincentL Drug metabolism and clearance system in tumor cells of patients with multiple myeloma Oncotarget 2015 6 6431 47 10.18632/oncotarget.3237 Open DOISearch in Google Scholar

53. Kassambara A, Gourzones-Dmitriev C, Sahota S, Reme T, Moreaux J, Goldschmidt H, et al. A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy. Oncotarget 2014; 5: 2487–98. doi: 10.18632/oncotarget.1740 KassambaraA Gourzones-DmitrievC SahotaS RemeT MoreauxJ GoldschmidtH A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy Oncotarget 2014 5 2487 98 10.18632/oncotarget.1740 Open DOISearch in Google Scholar

54. He WZ, Jiang C, Liu LL, Yin CX, Rong YM, Hu WM, et al. Association of body composition with survival and inflammatory responses in patients with nonmetastatic nasopharyngeal cancer. Oral Oncology 2020; 108: 104771. doi: 10.1016/j.oraloncology.2020.104771 HeWZ JiangC LiuLL YinCX RongYM HuWM Association of body composition with survival and inflammatory responses in patients with nonmetastatic nasopharyngeal cancer Oral Oncology 2020 108 104771 10.1016/j.oraloncology.2020.104771 Open DOISearch in Google Scholar

55. Caan BJ, Feliciano EMC, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol 2018; 4: 798–804. doi: 10.1001/jamaoncol.2018.0137 CaanBJ FelicianoEMC PradoCM AlexeeffS KroenkeCH BradshawP Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer JAMA Oncol 2018 4 798 804 10.1001/jamaoncol.2018.0137 Open DOISearch in Google Scholar

56. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48: 73–85. doi: 10.2307/2532740 LausenB SchumacherM Maximally selected rank statistics Biometrics 1992 48 73 85 10.2307/2532740 Open DOISearch in Google Scholar

57. Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017; 36: 49–64. doi: 10.1016/j.clnu.2016.09.004 CederholmT BarazzoniR AustinP BallmerP BioloG BischoffSC ESPEN guidelines on definitions and terminology of clinical nutrition Clin Nutr 2017 36 49 64 10.1016/j.clnu.2016.09.004 Open DOISearch in Google Scholar

58. Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 2015; 63: 131–40. doi: 10.1016/j.jhep.2015.02.031 FujiwaraN NakagawaH KudoY TateishiR TaguriM WatadaniT Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma J Hepatol 2015 63 131 40 10.1016/j.jhep.2015.02.031 Open DOISearch in Google Scholar

59. McSorley ST, Black DH, Horgan PG, McMillan DC. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin Nutr 2018; 37: 1279–85. doi: 10.1016/j.clnu.2017.05.017 McSorleyST BlackDH HorganPG McMillanDC The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer Clin Nutr 2018 37 1279 85 10.1016/j.clnu.2017.05.017 Open DOISearch in Google Scholar

60. Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539–47. doi: 10.1200/jco.2012.45.2722 MartinL BirdsellL MacDonaldN ReimanT ClandininMT McCargarLJ Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index J Clin Oncol 2013 31 1539 47 10.1200/jco.2012.45.2722 Open DOISearch in Google Scholar

61. Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020; 54: 237–46. doi: 10.2478/raon-2020-0016 SrpcicM JordanT PopuriK SokM Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer Radiol Oncol 2020 54 237 46 10.2478/raon-2020-0016 Open DOISearch in Google Scholar

62. Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 2020; 145: 102839. doi: 10.1016/j.critrevonc.2019.102839 AleixoGFP ShacharSS NyropKA MussHB MalpicaL WilliamsGR Myosteatosis and prognosis in cancer: systematic review and meta-analysis Crit Rev Oncol Hematol 2020 145 102839 10.1016/j.critrevonc.2019.102839 Open DOISearch in Google Scholar

63. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001; 2: 141–7. doi: 10.1046/j.1467-789x.2001.00031.x PrenticeAM JebbSA Beyond body mass index Obes Rev 2001 2 141 7 10.1046/j.1467-789x.2001.00031.x Open DOISearch in Google Scholar

64. Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Kamo N, et al. Impact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases. World J Surg 2018; 42: 1180–91. doi: 10.1007/s00268-017-4255-5 KobayashiA KaidoT HamaguchiY OkumuraS ShiraiH KamoN Impact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases World J Surg 2018 42 1180 91 10.1007/s00268-017-4255-5 Open DOISearch in Google Scholar

65. Rickles AS, Iannuzzi JC, Mironov O, Deeb AP, Sharma A, Fleming FJ, et al. Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg 2013; 17: 133–43; discussion p.43. doi: 10.1007/s11605-012-2045-9 RicklesAS IannuzziJC MironovO DeebAP SharmaA FlemingFJ Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg 2013 17 133 43 discussion p.43. 10.1007/s11605-012-2045-9 Open DOISearch in Google Scholar

66. Smith AD, Gray MR, del Campo SM, Shlapak D, Ganeshan B, Zhang X, et al. Predicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and RECIST stable disease on initial posttherapy images using CT texture analysis. AJR Am J Roentgenol 2015; 205: W283–93. doi: 10.2214/ajr.15.14315 SmithAD GrayMR del CampoSM ShlapakD GaneshanB ZhangX Predicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and RECIST stable disease on initial posttherapy images using CT texture analysis AJR Am J Roentgenol 2015 205 W283 93 10.2214/ajr.15.14315 Open DOISearch in Google Scholar

67. Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015; 157: 1088–98. doi: 10.1016/j.surg.2015.02.002 OkumuraS KaidoT HamaguchiY FujimotoY MasuiT MizumotoM Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer Surgery 2015 157 1088 98 10.1016/j.surg.2015.02.002 Open DOISearch in Google Scholar

68. He AQ, Li CQ, Zhang Q, Liu T, Liu J, Liu G. Visceral-to-subcutaneous fat ratio is a potential predictor of postoperative complications in colorectal cancer. Med Sci Monit 2021; 27: e930329. doi: 10.12659/msm.930329 HeAQ LiCQ ZhangQ LiuT LiuJ LiuG Visceral-to-subcutaneous fat ratio is a potential predictor of postoperative complications in colorectal cancer Med Sci Monit 2021 27 e930329 10.12659/msm.930329 Open DOISearch in Google Scholar

69. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7: 410–20. doi: 10.1016/j.cmet.2008.04.004 TranTT YamamotoY GestaS KahnCR Beneficial effects of subcutaneous fat transplantation on metabolism Cell Metab 2008 7 410 20 10.1016/j.cmet.2008.04.004 Open DOISearch in Google Scholar

70. Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer 2017; 117: 148–55. doi: 10.1038/bjc.2017.149 EbadiM MartinL GhoshS FieldCJ LehnerR BaracosVE Subcutaneous adiposity is an independent predictor of mortality in cancer patients Br J Cancer 2017 117 148 55 10.1038/bjc.2017.149 Open DOISearch in Google Scholar

71. Ebadi M, Baracos VE, Bathe OF, Robinson LE, Mazurak VC. Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content. Clin Nutr 2016; 35: 1347–53. doi: 10.1016/j.clnu.2016.02.014 EbadiM BaracosVE BatheOF RobinsonLE MazurakVC Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content Clin Nutr 2016 35 1347 53 10.1016/j.clnu.2016.02.014 Open DOISearch in Google Scholar

72. Di Prata C, Renouf B, Tzanis D, Bouhadiba T, Watson S, Zein SE, et al. Significant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center. Ann Surg Oncol 2023; 30: 4515–26. doi: 10.1245/s10434-023-13459-7 Di PrataC RenoufB TzanisD BouhadibaT WatsonS ZeinSE Significant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center Ann Surg Oncol 2023 30 4515 26 10.1245/s10434-023-13459-7 Open DOISearch in Google Scholar

73. Nasirishargh A, Grova M, Bateni CP, Judge SJ, Nuno MA, Basmaci UN, et al. Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma. J Surg Oncol 2023; 127: 855–61. doi: 10.1002/jso.27199 NasirisharghA GrovaM BateniCP JudgeSJ NunoMA BasmaciUN Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma J Surg Oncol 2023 127 855 61 10.1002/jso.27199 Open DOISearch in Google Scholar

74. Choi ES, Kim HS, Han I. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. Ann Surg Oncol 2014; 21: 778–85. doi: 10.1245/s10434-013-3418-3 ChoiES KimHS HanI Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma Ann Surg Oncol 2014 21 778 85 10.1245/s10434-013-3418-3 Open DOISearch in Google Scholar

75. Fiore M, Ljevar S, Pasquali S, Morelli D, Callegaro D, Sanfilippo R, et al. Preoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers prognostic index for primary retroperitoneal sarcomas: retrospective monocentric study. Clin Cancer Res 2023; 29: 614–20. doi: 10.1158/1078-0432.CCR-22-2897 FioreM LjevarS PasqualiS MorelliD CallegaroD SanfilippoR Preoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers prognostic index for primary retroperitoneal sarcomas: retrospective monocentric study Clin Cancer Res 2023 29 614 20 10.1158/1078-0432.CCR-22-2897 Open DOISearch in Google Scholar

76. Schwartz PB, Poultsides G, Roggin K, Howard JH, Fields RC, Clarke CN, et al. PLR and NLR are poor predictors of survival outcomes in sarcomas: a new perspective from the USSC. J Surg Res 2020; 251: 228–38. doi: 10.1016/j.jss.2020.01.008 SchwartzPB PoultsidesG RogginK HowardJH FieldsRC ClarkeCN PLR and NLR are poor predictors of survival outcomes in sarcomas: a new perspective from the USSC J Surg Res 2020 251 228 38 10.1016/j.jss.2020.01.008 Open DOISearch in Google Scholar

77. Netanyahu Y, Gerstenhaber F, Shamai S, Sher O, Merimsky O, Klausner JM, et al. Innate inflammatory markers for predicting survival in retroperitoneal sarcoma. J Surg Oncol 2020; 122: 1655–61. doi: 10.1002/jso.26178 NetanyahuY GerstenhaberF ShamaiS SherO MerimskyO KlausnerJM Innate inflammatory markers for predicting survival in retroperitoneal sarcoma J Surg Oncol 2020 122 1655 61 10.1002/jso.26178 Open DOISearch in Google Scholar

78. Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Desai A, Gladdy RA, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic australasian RPS Working Group. Ann Surg Oncol 2021; 28: 7873–88. doi: 10.1245/s10434-021-09654-z SwallowCJ StraussDC BonvalotS RutkowskiP DesaiA GladdyRA Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic australasian RPS Working Group Ann Surg Oncol 2021 28 7873 88 10.1245/s10434-021-09654-z Open DOISearch in Google Scholar

79. Fearon KC, Luff R. The nutritional management of surgical patients: enhanced recovery after surgery. Proc Nutr Soc 2003; 62: 807–11. doi: 10.1079/PNS2003299 FearonKC LuffR The nutritional management of surgical patients: enhanced recovery after surgery Proc Nutr Soc 2003 62 807 11 10.1079/PNS2003299 Open DOISearch in Google Scholar